Syndax Pharmaceuticals Inc (SNDX)
22.05
+0.19
(+0.87%)
USD |
NASDAQ |
May 03, 16:00
22.04
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Operations (Quarterly): -41.35M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.35M |
| September 30, 2023 | -44.65M |
| June 30, 2023 | -35.37M |
| March 31, 2023 | -39.23M |
| December 31, 2022 | -22.89M |
| September 30, 2022 | -28.54M |
| June 30, 2022 | -40.31M |
| March 31, 2022 | -41.93M |
| December 31, 2021 | 100.71M |
| September 30, 2021 | -24.94M |
| June 30, 2021 | -24.04M |
| March 31, 2021 | -22.59M |
| December 31, 2020 | -15.63M |
| September 30, 2020 | -18.30M |
| June 30, 2020 | -21.41M |
| March 31, 2020 | -15.92M |
| December 31, 2019 | -12.73M |
| September 30, 2019 | -8.529M |
| June 30, 2019 | -12.52M |
| March 31, 2019 | -16.83M |
| December 31, 2018 | -15.04M |
| September 30, 2018 | -18.47M |
| Date | Value |
|---|---|
| June 30, 2018 | -15.15M |
| March 31, 2018 | -19.87M |
| December 31, 2017 | -12.72M |
| September 30, 2017 | -10.18M |
| June 30, 2017 | -11.80M |
| March 31, 2017 | -12.67M |
| December 31, 2016 | -10.42M |
| September 30, 2016 | -11.45M |
| June 30, 2016 | -6.89M |
| March 31, 2016 | -6.403M |
| December 31, 2015 | -4.295M |
| September 30, 2015 | -5.182M |
| June 30, 2015 | -3.996M |
| March 31, 2015 | 11.04M |
| December 31, 2014 | -3.475M |
| September 30, 2014 | -2.602M |
| June 30, 2014 | -3.804M |
| March 31, 2014 | -4.512M |
| December 31, 2013 | -2.756M |
| September 30, 2013 | -2.127M |
| June 30, 2013 | -0.927M |
| March 31, 2013 | -1.485M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-44.65M
Minimum
Sep 2023
100.71M
Maximum
Dec 2021
-19.48M
Average
-22.89M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| SpringWorks Therapeutics Inc | -78.93M |
| Alnylam Pharmaceuticals Inc | -81.52M |
| Geron Corp | -62.25M |
| Ionis Pharmaceuticals Inc | 32.86M |
| Madrigal Pharmaceuticals Inc | -79.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -16.29M |
| Cash from Financing (Quarterly) | 258.48M |
| Free Cash Flow | -160.60M |
| Free Cash Flow Per Share (Quarterly) | -0.57 |
| Free Cash Flow Yield | -10.35% |